142 related articles for article (PubMed ID: 6966548)
1. Studies of lymphocytotoxins in infectious mononucleosis and systemic lupus erythematosus: evidence for immune complex-mediated cytotoxicity.
Quin JW; Charlesworth JA; Bowman C; Macdonald GJ
Clin Exp Immunol; 1980 Mar; 39(3):593-8. PubMed ID: 6966548
[TBL] [Abstract][Full Text] [Related]
2. Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.
Quin JW; Charlesworth JA; Lee CH; Macdonald GJ
Clin Exp Immunol; 1980 Mar; 39(3):588-92. PubMed ID: 6966547
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytotoxic activity in primary glomerulonephritis: evidence for immune complex-mediated cytotoxicity.
Charlesworth JA; Bowman C; Perl SI; Yasmeen D; Pussell BA
J Clin Lab Immunol; 1981 Nov; 6(3):233-6. PubMed ID: 6978404
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytotoxic antibodies in systemic lupus erythematosus: evidence for reactivity with i antigen.
Goldberg LS; Bresnihan B; Hughes GR
Clin Exp Immunol; 1978 Mar; 31(3):443-7. PubMed ID: 657589
[TBL] [Abstract][Full Text] [Related]
5. Normal human serum inhibits the lymphocytotoxicity of sera from patients with infectious mononucleosis.
Peake P; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1983 Jun; 52(3):671-7. PubMed ID: 6872321
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
7. Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus.
Pussell BA; Blyth F; Charlesworth JA
Clin Exp Immunol; 1982 Jan; 47(1):133-7. PubMed ID: 7094418
[TBL] [Abstract][Full Text] [Related]
8. IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera.
Morland C; Michael J; Adu D
Clin Nephrol; 1989 Apr; 31(4):204-9. PubMed ID: 2714025
[TBL] [Abstract][Full Text] [Related]
9. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
[TBL] [Abstract][Full Text] [Related]
10. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
11. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
12. The production of antibody-dependent cellular cytotoxicity by immune complexes in systemic lupus erythematosus.
Penning CA; Hughes P; Rowell NR
J Clin Lab Immunol; 1984 Mar; 13(3):123-7. PubMed ID: 6716450
[TBL] [Abstract][Full Text] [Related]
13. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
Medof ME; Oger JJ; Antel JP; Prince GM
J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus.
Miyoshi Y; Kilpatrick KA; Kelley RO; Searles RP; Williams RC
J Rheumatol; 1985 Dec; 12(6):1097-104. PubMed ID: 4093915
[TBL] [Abstract][Full Text] [Related]
15. Cold insoluble globulin: relationship with lymphocytotoxins in autoimmune diseases.
Ferraccioli GF; Osterland CK
Clin Exp Rheumatol; 1984; 2(4):329-32. PubMed ID: 6335864
[TBL] [Abstract][Full Text] [Related]
16. beta 2 microglobulin binding activity associated with lymphocytotoxic antibodies in sera containing multiple autoantibodies.
Barnes RM; Steen S; Kenton P
J Clin Lab Immunol; 1984 Jul; 14(3):135-40. PubMed ID: 6384521
[TBL] [Abstract][Full Text] [Related]
17. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.
Morimoto C; Sano H; Abe T; Homma M; Steinberg AD
J Immunol; 1982 Nov; 129(5):1960-5. PubMed ID: 7119438
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytotoxins in epileptic patients receiving phenytoin.
Ooi BS; Kant KS; Hanenson IB; Pesce AJ; Pollak VE
Clin Exp Immunol; 1977 Oct; 30(1):56-61. PubMed ID: 304779
[TBL] [Abstract][Full Text] [Related]
20. Serum-induced enhancement of peripheral blood mononuclear cell mediated cytotoxicity towards human target cells in systemic lupus erythematosus.
Wright JK; Penning CA; Ashby JC; Cunningham J; Rowell NR; Hughes P
J Clin Lab Immunol; 1983 Jun; 11(2):81-5. PubMed ID: 6876144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
